Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea

Authors:

Abstract
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea Sung Yong Lee, Chang-Min Choi, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Ji Young Park, Young-Chul Kim, In-Jae Oh, Chi Young Jung, Sang Hoon Lee, Seong Hoon Yoon, Juwhan Choi, Tae Won Jang

This publication has 50 references indexed in Scilit: